UBRIGENE
宜明细胞
UBRIGENE
Biotech/Healthcare
Founded in October 2015, Yiming (Beijing) Cell Biotechnology Co., Ltd. is an R&D-focused biotech company developing and applying gene and cell therapy technologies.
Latest round: Series C Extension (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-04-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.